Basel, 9 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab ...
The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...
Potential approval of ORPATHYS could further strengthen Tagrisso by extending its use to patients whose cancers develop ...
Zacks Investment Research on MSN
AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer
AbbVie ABBV announced that the FDA has granted two Breakthrough Therapy designations (BTDs) to its investigational ...
NORTH CHICAGO - AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration ( FDA) has granted two Breakthrough Therapy Designations (BTDs) for telisotuzumab adizutecan (Temab-A; ABBV-400 ...
PRNewswire/ -- (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced the publication ...
At the Policlinico di Roma, the drug YntraDose was administered to a 63-year-old female patient suffering from inoperable ductal adenocarcinoma ...
A teenager has been given pioneering surgery to preserve his fertility after chemotherapy treatment. For the first time in ...
NSCLC development advances after FDA Breakthrough Therapy Designation for previously treated EGFR wild-type, c-Met disease.
"Rocky" franchise star Dolph Lundgren was considering ending his life after a yearslong battle with kidney cancer. A second opinion "saved" him.
The vaccine, called SurVaxM, aims to prevent the recurrence of glioblastoma, an aggressive brain cancer with few major advances in treatment.
UCLA oncologist Dr. Dennis Slamon has received the 2026 Albany Prize for discoveries that identified HER2-positive breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results